Clinical Trial Update: 1.2% Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial tested a 1.2% rosuvastatin gel as a local treatment for chronic periodontitis in smokers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• rosuvastatin gel (1.2% local gel) (rosuvastatin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis | Phase 2, Phase 3 | Status: COMPLETED